Surmodics, Inc. (SRDX): Price and Financial Metrics

SRDX POWR Grades

• SRDX scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.49% of US stocks.
• SRDX's strongest trending metric is Stability; it's been moving down over the last 177 days.
• SRDX's current lowest rank is in the Growth metric (where it is better than 15.97% of US stocks).

SRDX Stock Summary

• SRDX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.92 -- higher than only 15.63% of US-listed equities with positive expected earnings growth.
• With a year-over-year growth in debt of 194.95%, SURMODICS INC's debt growth rate surpasses 93.16% of about US stocks.
• Over the past twelve months, SRDX has reported earnings growth of -873.95%, putting it ahead of merely 2.18% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to SURMODICS INC, a group of peers worth examining would be KLIC, ICPT, ACAD, SPRO, and PALT.
• Visit SRDX's SEC page to see the company's official filings. To visit the company's web site, go to www.surmodics.com.

SRDX Valuation Summary

• In comparison to the median Healthcare stock, SRDX's EV/EBIT ratio is 254.55% lower, now standing at -10.2.
• SRDX's EV/EBIT ratio has moved down 49.7 over the prior 243 months.

Below are key valuation metrics over time for SRDX.

SRDX Growth Metrics

Its 5 year revenue growth rate is now at 37.07%.
• Its 2 year revenue growth rate is now at -3.62%.
• Its 5 year net cashflow from operations growth rate is now at -33.79%.

Over the past 34 months, SRDX's revenue has gone up $1,283,000.

The table below shows SRDX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	101.881	-20.999	-32.305
2022-09-30	99.951	-17.223	-27.274
2022-06-30	97.934	-13.834	-12.835
2022-03-31	96.953	-7.582	-10.471
2021-12-31	105.842	12.633	1.699
2021-09-30	105.136	15.389	4.237

SRDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SRDX has a Quality Grade of B, ranking ahead of 94.57% of graded US stocks.
• SRDX's asset turnover comes in at 0.604 -- ranking 71st of 186 Medical Equipment stocks.
• MMSI, POAI, and OSUR are the stocks whose asset turnover ratios are most correlated with SRDX.

The table below shows SRDX's key quality metrics over time.